“…This combines the ability for multivalent target–ligand interactions, with the increased cellular uptake seen for rigid particles. , Furthermore, SCNPs with PTR86, a targeting ligand for pancreatic cancer, have been shown to accumulate at the tumor site in a murine model, demonstrating that SCNPs can avoid fast renal clearance . These characteristics have led to SCNPs being investigated in various biomedical applications, such as drug delivery, ,− targeting, , protein mimicry, − imaging, , sensing, and even catalysis. ,, …”